SCHEMBL4685571

SCHEMBL4685571

COc1cc2c(cc1F)CC/C2=C\C#N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
MAPT P10636 5/20 0.40
MAPK1 P28482 3/20 0.40
HPGD P15428 3/20 0.37
KDM4E B2RXH2 3/20 0.37
HSD17B10 Q99714 2/20 0.37
KDM4A O75164 1/20 0.37
ALOX15 P16050 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
ABCB1 P08183 1/20 0.35
CYP19A1 P11511 2/20 0.35
CYP11B2 P19099 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
S1PR2 O95136 1/20 0.33
PTGS2 P35354 1/20 0.33
GAA P10253 1/20 0.33
MAOA P21397 1/20 0.33
EGFR P00533 1/20 0.32
PDE4A P27815 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4690945 1.00 ALDH1A1 (0.40) ALDH1A1MAPTMAPK1HPGDKDM4E
SCHEMBL4685573 1.00 ALDH1A1 (0.40) ALDH1A1MAPTMAPK1HPGDKDM4E
SCHEMBL7953939 0.88 MAPT (0.50) ALDH1A1MAPTMAPK1HPGDKDM4E
SCHEMBL7953943 0.88 MAPT (0.50) ALDH1A1MAPTMAPK1HPGDKDM4E
SCHEMBL7779856 0.84 HTR2A (0.44) ALDH1A1MAPTMAPK1HPGDKDM4E
SCHEMBL7779864 0.84 HTR2A (0.44) ALDH1A1MAPTMAPK1HPGDKDM4E
SCHEMBL7779860 0.84 HTR2A (0.44) ALDH1A1MAPTMAPK1HPGDKDM4E
SCHEMBL7951877 0.79 CYP19A1 (0.55) ALDH1A1MAPTMAPK1HPGDKDM4E
SCHEMBL7951875 0.79 CYP19A1 (0.55) ALDH1A1MAPTMAPK1HPGDKDM4E
SCHEMBL7779852 0.77 CYP1A2 (0.40) ALDH1A1MAPTMAPK1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885210-B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use TAKEDA PHARMACEUTICAL (JP) 2008-06-18 EP disclosed
EP-1550655-A1 Bicyclic intermediates Takeda Pharmaceutical Company Limited (JP) 2005-07-06 EP disclosed
EP-0885210-B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-06-12 EP disclosed
EP-1199304-A1 Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders Takeda Chemical Industries, Ltd. (JP) 2002-04-24 EP disclosed
EP-0848699-B1 BENZOCYCLOALKENE COMPOUNDS WITH MELATONINE RECEPTOR BINDING AFFINITY, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2001-10-24 EP disclosed
US-6218429-B1 TREATING MELATONIN RELATED DISORDERS (E.G. CIRCARDIAN RHYTHMS, SLEEP-AWAKE CYCLES, TIME ZONE CHANGES, SLEEP DISORDERS) TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-04-17 US disclosed
US-6034239-A BINDIG TO MELATONIN RECEPTORS; SLEEP DISORDERS; GLANDULAR DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-03-07 US disclosed
US-5922771-A MELATONIN RECEPTOR AGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-07-13 US disclosed